Hexalen

In the US, Hexalen (altretamine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Ovarian Cancer.

US matches:

• Hexalen

Ingredient matches for Hexalen

Altretamine

Altretamine is reported as an ingredient of Hexalen in the following countries:

• United States

Hexetidine

Hexetidine is reported as an ingredient of Hexalen in the following countries:

• Greece

International Drug Name Search

Ambistryn

Ambistryn may be available in the countries listed below.

Ingredient matches for Ambistryn

Streptomycin

Streptomycin sulfate (a derivative of Streptomycin) is reported as an ingredient of Ambistryn in the following countries:

• India

International Drug Name Search

Naloxonum Hydrochloricum

Naloxonum Hydrochloricum may be available in the countries listed below.

Ingredient matches for Naloxonum Hydrochloricum

Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Naloxonum Hydrochloricum in the following countries:

• Poland

International Drug Name Search

Amevive

In the US, Amevive (alefacept systemic) is a member of the drug class selective immunosuppressants and is used to treat Psoriasis.

US matches:

• Amevive

Ingredient matches for Amevive

Alefacept

Alefacept is reported as an ingredient of Amevive in the following countries:

• Canada


• United States

International Drug Name Search

Redoxitos

Redoxitos may be available in the countries listed below.

Ingredient matches for Redoxitos

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Redoxitos in the following countries:

• Colombia

International Drug Name Search

Primovist

Primovist may be available in the countries listed below.

UK matches:

• Primovist 0.25 mmol/ml, solution for injection, prefilled syringe (SPC)

Ingredient matches for Primovist

Gadoxetic Acid

Gadoxetic Acid disodium (a derivative of Gadoxetic Acid) is reported as an ingredient of Primovist in the following countries:

• Australia


• Austria


• Czech Republic


• Estonia


• Finland


• Germany


• Hungary


• Italy


• Latvia


• Lithuania


• Luxembourg


• Malta


• Norway


• Poland


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Carbagamma

Carbagamma may be available in the countries listed below.

Ingredient matches for Carbagamma

Carbamazepine

Carbamazepine is reported as an ingredient of Carbagamma in the following countries:

• Germany

International Drug Name Search

Benzolac

Benzolac may be available in the countries listed below.

Ingredient matches for Benzolac

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Benzolac in the following countries:

• Indonesia

International Drug Name Search

Benclamid

Benclamid may be available in the countries listed below.

Ingredient matches for Benclamid

Glibenclamide

Glibenclamide is reported as an ingredient of Benclamid in the following countries:

• Argentina

International Drug Name Search

Somnovit

Somnovit may be available in the countries listed below.

Ingredient matches for Somnovit

Loprazolam

Loprazolam is reported as an ingredient of Somnovit in the following countries:

• Spain

International Drug Name Search

Remicade

Pronunciation: in-FLIX-i-mab
Generic Name: Infliximab
Brand Name: Remicade

Patients who use Remicade have an increased risk of developing serious and sometimes fatal infections (eg, bacterial, viral, or fungal infections; tuberculosis [TB]). Most patients who developed these infections were taking medicines that suppressed their immune systems (eg, methotrexate, corticosteroids).

TB may be caused by a new infection or by reactivation of a previous infection. You should be tested for TB infection before you start Remicade. If you have a TB infection, treatment for TB should be started before you begin Remicade. Tell your doctor right away if you develop symptoms of infection, such as fever, chills, persistent cough or sore throat, unusual vaginal discharge, painful or frequent urination, or a persistent feeling of being unwell. Tell your doctor if you have a history of chronic or recurrent infections.

Remicade is a tumor necrosis factor (TNF) blocker. Lymphoma and other types of cancer have been reported in children and teenagers treated with TNF blockers. This has been fatal in some cases. Talk with your doctor for more information.

A rare type of cancer called hepatosplenic T-cell lymphoma (HSTCL) has rarely occurred in teenagers and young adults using TNF blockers, including Remicade, to treat Crohn disease or ulcerative colitis. These cases have been fatal. Patients who developed this cancer were using Remicade along with certain other medicines (azathioprine or 6-mercaptopurine). Tell your doctor if you have or have ever had any type of cancer.

Remicade is used for:

Treating moderate to severe rheumatoid arthritis when used along with another medicine (methotrexate). It is also used to treat ankylosing spondylitis, psoriatic arthritis, and certain types of skin psoriasis (eg, plaque psoriasis). Remicade is used to treat moderate to severe Crohn disease or ulcerative colitis in certain patients who have not received relief from other treatments. It may also be used for other conditions as determined by your doctor.

Remicade is a monoclonal antibody. It works by blocking the action of a substance in the body called TNF. This may reduce the inflammation and immune responses caused by TNF.

Do NOT use Remicade if:

• you are allergic to any ingredient in Remicade, including mouse-derived (murine) proteins


• you have moderate to severe heart failure, unless your doctor has examined you and decided that you are able to take Remicade. Certain doses of Remicade should not be used in patients who have moderate to severe heart failure. Ask your doctor if you have questions about this information


• you have an active infection


• you are taking abatacept, an interleukin-1 blocker (eg, anakinra), or tocilizumab

Contact your doctor or health care provider right away if any of these apply to you.

Before using Remicade:

Some medical conditions may interact with Remicade. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have any type of infection, including bacterial or viral infection, fungal infection (eg, coccidiomycosis, histoplasmosis), TB infection, skin infection, or open cuts or sores on your body


• if you have a history of chronic or recurrent infections, TB or a positive TB skin test, or if you have recently been around someone who has had TB


• if you have conditions that may increase your risk of infection (eg, diabetes) or if you have traveled to or lived in an area where TB or other certain infections (eg, histoplasmosis, coccidioidomycosis, blastomycosis) are common


• if you have a history of immune system problems (eg, weakened immune system), blood problems, bone marrow problems, or lymphoma or other cancers


• if you have a history of liver problems (eg, hepatitis B), liver problems caused by drinking alcohol (alcoholic hepatitis), or hepatitis B virus reactivation when taking Remicade or other TNF blockers


• if you have any numbness or tingling or a disease that affects your nervous system (eg, multiple sclerosis [MS], Guillain-Barré syndrome, seizures)


• if you have heart problems (eg, congestive heart failure)


• if you have had phototherapy to treat psoriasis or other skin conditions


• if you have recently received or are scheduled to receive a vaccine


• if you have chronic obstructive pulmonary disease (COPD) or a history of smoking


• if you have been taking another medicine to treat rheumatoid arthritis

Some MEDICINES MAY INTERACT with Remicade. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Corticosteroids (eg, prednisone), costimulation modulators (eg, abatacept), immunosuppressants (eg, cyclosporine), interleukin-1 blockers (eg, anakinra), methotrexate, or tocilizumab because the risk of serious infections may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Remicade may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Remicade:

Use Remicade as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Remicade comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Remicade refilled.


• Remicade is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Remicade at home, a health care provider will teach you how to use it. Be sure you understand how to use Remicade. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• You may receive other medicines before each treatment with Remicade to decrease the chance of an infusion-related reaction. Discuss any questions with your doctor.


• If you miss a dose of Remicade, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Remicade.

Important safety information:

• Remicade may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Remicade with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not receive a live vaccine (eg, measles, mumps) while you are using Remicade. Talk with your doctor before you receive any vaccine.


• Before you use Remicade, discuss your vaccination history with your doctor to be sure that you are up to date on vaccinations.


• Tell your doctor or dentist that you take Remicade before you receive any medical or dental care, emergency care, or surgery.


• Remicade may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Do not touch your eyes or the inside of your nose unless you have thoroughly washed your hands first. If you develop a fever, feel very tired, have a cough, or have flu-like symptoms, these could be signs that you may be getting an infection. If any of these symptoms occur, contact your doctor at once.


• Remicade may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.


• Remicade may increase the risk of developing a certain type of blood cancer (lymphoma) or other types of cancer. The risk may increase if you have used Remicade for a long time. Tell your doctor if you have ever had lymphoma or another cancer. Contact your doctor right away if any symptoms appear, such as unusual lumps or swelling (eg, in your armpit, groin, or neck), night sweats, recurring fever, unusual tiredness, unexplained cough or breathlessness, persistent unexplained itching, or unexplained weight loss.


• New or worsening nervous system disorders (eg, MS, Guillain-Barré syndrome, seizures) have occurred in patients who take Remicade. Tell your doctor if you have a disease that affects your nervous system. Discuss any questions or concerns with your doctor.


• Some patients who use Remicade have developed new or worsening psoriasis. Tell your doctor right away if you notice any new or worsening skin problems (eg, red, flaky, or itchy skin patches).


• Rarely, severe liver problems have occurred with the use of Remicade. These liver problems may occur from 2 weeks to more than a year after starting Remicade. Contact your doctor right away if you develop dark urine, pale stools, severe or persistent stomach pain, or yellowing of the skin or eyes.


• Some patients receiving Remicade have experienced an allergic reaction. Some allergic reactions have been severe. If such a reaction occurs, it has usually happened during treatment with Remicade or within 2 hours after treatment. However, allergic reactions have also occurred up to 12 days after the use of Remicade. Tell your doctor if symptoms such as fever, chills, rash, hives, headache, dizziness, chest pain, muscle or joint pain, swelling, sore throat, or trouble breathing or swallowing occur.


• Rarely, temporary vision loss or a heart attack have been reported during treatment with Remicade or within 2 hours after treatment. Tell your doctor right away if you experience vision loss or other vision changes; chest pain; numbness of an arm or leg; sudden, severe headache or vomiting; or fainting.


• Remicade may interfere with certain lab tests, including tests for TB infection. Be sure your doctor and lab personnel know you are using Remicade.


• Lab tests, including TB, liver function, and complete blood cell counts, may be performed while you use Remicade. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Remicade with caution in the ELDERLY; they may be more sensitive to its effects, especially the risk of infection.


• Caution is advised when using Remicade in CHILDREN; they may be more likely to develop certain side effects. These effects may include certain blood problems (eg, anemia, low white blood cell levels), blood in the stool, flushing, bone fracture, certain types of infection, and certain allergic reactions. Cases of unusual cancer have occurred in children and teenagers using Remicade.


• Remicade should be used with extreme caution in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: It is not known if Remicade can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Remicade while you are pregnant. It is not known if Remicade is found in breast milk. Do not breast-feed while taking Remicade.

Possible side effects of Remicade:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; headache; mild stomach pain or upset; pain, redness, or swelling at the injection site; runny or stuffy nose; tiredness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody, black, or tarry stools; butterfly-shaped rash on the nose and cheeks; change in the amount of urine produced; change in the appearance of a mole; chest pain; dark urine; dizziness; fainting; fast, slow, or irregular heartbeat; flushing; joint or muscle pain; loss of appetite; nausea, vomiting, or diarrhea; numbness or tingling of the skin, arms, or legs; pale stools; red, swollen, blistered, or peeling skin; seizures; severe or persistent headache; severe or persistent stomach or back pain; shortness of breath; sudden, unexplained weight gain or loss; suicidal thoughts or attempts; swelling of the hands, legs, feet, or ankles; symptoms of infection (eg, fever or chills, painful or frequent urination, persistent cough or sore throat, flu-like symptoms, persistent feeling of being unwell, unusual vaginal discharge or odor, white patches in the mouth, red or painful skin); trouble swallowing; unusual bruising or bleeding; unusual lumps; unusual skin growths or other skin changes; unusual tiredness or weakness; very pale skin; vision changes; weakness in the arms or legs; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Remicade side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Remicade:

Remicade is usually handled and stored by a health care provider. If you are using Remicade at home, store Remicade as directed by your pharmacist or health care provider. Keep Remicade out of the reach of children and away from pets.

General information:

• If you have any questions about Remicade, please talk with your doctor, pharmacist, or other health care provider.


• Remicade is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Remicade. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Remicade resources

• Remicade Side Effects (in more detail)
• Remicade Use in Pregnancy & Breastfeeding
• Remicade Drug Interactions
• Remicade Support Group
• 53 Reviews for Remicade - Add your own review/rating

• Remicade Prescribing Information (FDA)


• Remicade Consumer Overview


• Remicade Monograph (AHFS DI)


• Remicade Advanced Consumer (Micromedex) - Includes Dosage Information


• Infliximab Professional Patient Advice (Wolters Kluwer)

Compare Remicade with other medications

• Ankylosing Spondylitis
• Behcet's Disease
• Bullous Pemphigoid
• Celiac Disease
• Cogan's Syndrome
• Crohn's Disease
• Crohn's Disease, Acute
• Crohn's Disease, Maintenance
• Giant Cell Arteritis
• Inflammatory Bowel Disease
• Juvenile Idiopathic Arthritis
• Kawasaki Disease
• Neurosarcoidosis
• Pemphigoid
• Pemphigus
• Polychondritis
• Psoriasis
• Psoriatic Arthritis
• Pulmonary Fibrosis
• Pyoderma Gangrenosum
• Rheumatoid Arthritis
• SAPHO Syndrome
• Sarcoidosis
• Sjogren's Syndrome
• Subcorneal Pustular Dermatosis
• Toxic Epidermal Necrolysis
• Ulcerative Colitis
• Uveitis

Psorianol

Psorianol may be available in the countries listed below.

Ingredient matches for Psorianol

Dithranol

Dithranol is reported as an ingredient of Psorianol in the following countries:

• Romania

International Drug Name Search

Zopiclon Hexal

Zopiclon Hexal may be available in the countries listed below.

Ingredient matches for Zopiclon Hexal

Eszopiclone

Zopiclone is reported as an ingredient of Zopiclon Hexal in the following countries:

• Germany

International Drug Name Search

Ibuprofeno GP Pharm

Ibuprofeno GP Pharm may be available in the countries listed below.

Ingredient matches for Ibuprofeno GP Pharm

Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno GP Pharm in the following countries:

• Peru

International Drug Name Search

Controlip

Controlip may be available in the countries listed below.

Ingredient matches for Controlip

Fenofibrate

Fenofibrate is reported as an ingredient of Controlip in the following countries:

• Costa Rica


• El Salvador


• Guatemala


• Honduras


• Mexico


• Nicaragua


• Panama

International Drug Name Search